Quick Summary
- Q1 earnings release scheduled for April 23, with analysts forecasting approximately 9.6% year-over-year gains in both earnings per share and revenues
- Billed business (cardholder spending) increased 8% YoY in Q4 2025, though momentum has plateaued without signs of reacceleration
- Credit metrics remain healthy — write-off rates elevated modestly while reserve additions are decreasing
- Fiscal 2026 projections anticipate 9–10% revenue expansion with EPS ranging from $17.30 to $17.90, matching analyst consensus
- Analyst sentiment leans Moderate Buy, with a mean price objective of $352.60 (representing ~6.3% potential gain)
As American Express (AXP) prepares for its first-quarter 2026 earnings announcement on April 23, the financial services giant finds itself in a position that’s best described as stable rather than spectacular.
The company’s underlying business performance remains strong. Consumer spending continues at a healthy clip. Credit portfolio quality shows no concerning trends. Yet for a premium-valued equity that trades at elevated multiples, maintaining the status quo may not satisfy investor appetite for growth.
The Street’s consensus calls for roughly 9.6% annual growth across both bottom-line earnings and top-line revenues. While respectable, this projection lacks the excitement that typically drives meaningful share price appreciation.
The central concern centers on billed business — the industry term for total cardholder spending — which represents the most critical performance indicator for AXP. Fourth-quarter 2025 showed 8% year-over-year expansion, matching the full-year fiscal 2025 performance. However, after climbing from 6% in the first quarter of 2025 to 7% in the second quarter, growth momentum has stagnated.
This pattern increasingly resembles that of a mature, steady-state operator — a characterization that doesn’t justify the current 21.4x trailing price-to-earnings ratio.
Credit Portfolio Remains Sound
The credit quality picture offers little cause for alarm. Fourth-quarter write-offs totaled $1.27 billion, rising from $1.13 billion in the year-ago period, though the quarter-over-quarter increase remained contained.
Provision expenses increased to $1.41 billion from the third quarter’s $1.28 billion. However, the reserve addition component stood at only $141 million — considerably lower than the $222 million recorded in Q2 2025. This represents prudent portfolio management rather than emerging stress signals.
Net interest income climbed 12% annually, loan balances expanded 7%, and interest margins widened. These indicators suggest credit portfolio expansion that’s both profitable and well-managed. The overall assessment points to normalization rather than weakening conditions.
Cramer’s Tactical Recommendation
Jim Cramer recently addressed AXP shares on Mad Money, offering tactical guidance for investors considering positions ahead of the quarterly report.
“American Express almost always seems to retreat when we see the numbers and then runs a couple of days later,” Cramer noted. His recommendation: delay purchases until late on earnings day — or the subsequent trading session — to sidestep the “knee-jerk selling” that frequently occurs even following positive results.
Cramer has additionally highlighted AXP’s affluent customer demographics as a fundamental advantage. “Demand for premium products can stay strong even if the rest of the economy slows down,” he commented in early April.
Bank of America’s first-quarter results, released April 15, provide useful context for consumer spending patterns. Card transaction volumes rose 6% year-over-year, with strength concentrated in travel, services, and retail categories. Given Amex’s tilt toward higher-income demographics, comparable or superior performance seems probable — establishing high single-digit billed business growth as the baseline expectation for Q1.
AXP shares currently trade around 18.5x forward earnings estimates, approximately 20% below the December valuation peak. This multiple compression moderately reduces the hurdle for positive share price movement.
Fiscal 2026 guidance projects 9–10% revenue growth with EPS between $17.30 and $17.90 — representing roughly 14% annual earnings growth. Analyst forecasts remained largely stable following this guidance release.
Among the most recent 17 analyst recommendations, seven rate the stock as Buy, nine assign Hold ratings, and one recommends Sell. The consensus price target stands at $352.60, suggesting approximately 6.3% upside from present trading levels.
